Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT05955950
Other study ID # UP 5797/22
Secondary ID
Status Enrolling by invitation
Phase N/A
First received
Last updated
Start date November 5, 2022
Est. completion date July 5, 2024

Study information

Verified date June 2023
Source Instituto de Cardiologia do Rio Grande do Sul
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Introduction: Positive psychological's constructs have shown a direct effect on adherence to pharmacological treatment, diet, physical activity and general commitment to health, in the same way that negative ones, such as depression, anxiety and stress, are associated with worse cardiovascular outcomes and are prevalent in patients with infarction. Objective: To verify whether a gratitude intervention can improve self-care and improve negative psychological states in patients with recent myocardial infarction. Methods: Randomized, parallel clinical trial. The inclusion criteria will be patients with ST-segment elevation myocardial infarction (STEMI) with less than 12 hours of evolution and undergoing primary percutaneous coronary intervention (pPCI). Participants will respond to the socio-demographic and risk factors questionnaire and self-care (ASA-A), anxiety, depression and stress (DASS-21) and gratitude (QG-6) scales. They will be drawn into the gratitude intervention group or neutral events group according to the randomization list. Patients in the intervention group will be tasked with writing down 3 to 5 situations a day for which they are grateful, for 14 days. Patients in the control group will be asked to write down 3 to 5 situations a day that have impacted them, whether good or bad. Both groups will be reassessed after the intervention and after 6 months. Expected results: It is expected that the intervention group will improve self-care and the feeling of gratitude, modify behaviors and decrease negative affects, while the group without intervention will remain unchanged from the beginning of the study to 6 months.


Description:

Study design: Randomized, parallel clinical trial. The study will use a prospective experimental design with Condition and Time as independent variables. The condition has two levels that correspond to the experimental conditions: (a) Gratitude List (aspects of daily experience that one feels grateful for), (b) Any Event List (events of one's own choosing that impressed the participant during the day, whether positive or negative). Time is a repeated measures variable with three levels corresponding to the measurement times: (a) Pre-test (before the intervention), (b) Post-test (at 2 weeks after of the intervention - visit 1) and (c) ) Follow-up (from baseline to 6 months - visit 2). This follow-up period is based on the previous studies. Patients will be invited to participate in the study during hospitalization for AMI. If they agree to participate, they must sign the Free and Informed Consent Form. They will answer the socio-demographic questionnaire and risk factors and self-care scales (ASA-A), anxiety, depression and stress (DASS-21) and gratitude (QG-6). Envelopes will be opened after the initial interview. Participants will receive instructions for the intervention. Participants will be asked to allocate 10-20 minutes at the end of the day, before bed, for 14 days, to write the lists, according to their allocation group. Studies involving gratitude interventions generally last for two weeks as already explained. In each group, participants will make a list of up to five items, evaluating the activities of that day. The instructions for the groups were adapted and translated. For the intervention group (Gratitude List), the instructions will be: "During the day, many things happen in our lives, big and small, for which we can be grateful. Think about your day and write down up to five things in your life that you are grateful for." For the control group (List of any event), the instructions were: "During the day, there are many events in our lives, big and small, that end up affecting us. Think about your day and write down up to five things in your life that affected you." Patients will receive a small notebook for daily notes, starting on the day of discharge. Upon discharge, text messages will be sent to their cell phones with reminders not to forget to start and continue making lists. At the end of 2 weeks of the intervention, patients will be invited to return for a reassessment interview (visit 1), and again at the end of 6 months (visit 2). A 6-month follow-up will be necessary so that we can assess changes in behavior. To assess the improvement in self-care, the ASA-A scale will be used. To assess emotional factors, the DASS scale (which assesses anxiety, depression and stress) will be used. To assess gratitude in the face of life events, the QG-6 scale and for physical health, a dedicated questionnaire will be used. All scales will be used before and after.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 132
Est. completion date July 5, 2024
Est. primary completion date November 5, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria: - ST-segment elevation myocardial infarction (STEMI) patients - Undergoing primary percutaneous coronary intervention (pPCI). Exclusion Criteria: - Patients in need of ventilatory support; - Over 75 years of age; - Delirium or dementia reported by the attending physician. - Not able to answer the questionnaires. - Very high depression scores requiring referral to psychological care services

Study Design


Intervention

Behavioral:
Gratitude list
Participants must to write 3-5 words a day for 14 days about aspects of their daily experience that they are grateful for.
List of any event
Participants must to write 3-5 words a day for 14 days about events of your own choosing that impressed the participant during the day, whether positive or negative.

Locations

Country Name City State
Brazil Marcia Moura Schmidt Porto Alegre Rio Grande Do Sul

Sponsors (1)

Lead Sponsor Collaborator
Instituto de Cardiologia do Rio Grande do Sul

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in self-care scores Changes in self-care scores assessed from Appraisal of Self-care Agency (ASA) From baseline to 15 days and from baseline to 6 months
Primary Changes in negative psychological states Changes in DASS-21 scores From baseline to 15 days and from baseline to 6 months
Secondary Changes in gratitude scores Changes in Gratitude Questionnaire - GQ-6 scores From baseline to 15 days and from baseline to 6 months
Secondary Behavioral changes (physical activity, diet...) Changes in modifiable cardiovascular risk factors: cholesterol, triglycerides, smoking cessation, etc. From baseline to 15 days and from baseline to 6 months
See also
  Status Clinical Trial Phase
Recruiting NCT05759078 - Effect of INtravenous FERRic Carboxymaltose Onmortality and Cardiovascular Morbidity, and Quality of Life in Iron Deficient Patients With Recent Myocardial infarCTion Phase 4
Completed NCT06408636 - Prognostic Role of LA Strain in Acute Myocardial Infarction
Recruiting NCT06038994 - Prognostic Value of Surem TRAF3IP2 Level in Patients With Acute Myocardial Infarction
Recruiting NCT04968808 - Timing of FFR-guided PCI for Non-IRA in NSTEMI and MVD (OPTION-NSTEMI) N/A
Completed NCT03338504 - Determining the Mechanism of Myocardial Injury and Role of Coronary Disease in Type 2 Myocardial Infarction
Recruiting NCT03317691 - The ALERT-Pilot Study N/A
Active, not recruiting NCT05077683 - Direct Oral Anticoagulants for Prevention of lEft ventRIcular Thrombus After Anterior Acute Myocardial InFarction - APERITIF Phase 3
Recruiting NCT03957005 - Cardiovascular Risk Assessment Model in Patients With MI
Active, not recruiting NCT06141252 - Benefit of Hypothermia in OHCA Complicating AMI N/A
Not yet recruiting NCT04560023 - Effectiveness of Multimedia Exposure in Patients Transferred to Hospital Suffering From Acute Myocardial Infarction N/A
Terminated NCT03809689 - Study of Cardiac Lesions Angiogenesis by 68Ga-NODAGA-RGD Cardiac PET N/A
Recruiting NCT06430892 - RAPID-POP a Randomized Controlled Trial N/A
Completed NCT05118009 - Artificial Intelligence Based Rapid Identification of ST-elevation Myocardial Infarction Using Electrocardiogram (ARISE) N/A
Active, not recruiting NCT04753749 - Evaluation of a Modified Anti-Platelet Therapy Associated With Low-dose DES Firehawk in Acute Myocardial Infarction Patients Treated With Complete Revascularization Strategy N/A
Completed NCT04769219 - Secondary Prevention Education After Acute Myocardial Infarction N/A
Active, not recruiting NCT05350969 - Study to Assess Efficacy and Safety of CDR132L in Patients With Reduced Left Ventricular Ejection Fraction After Myocardial Infarction Phase 2
Recruiting NCT05999110 - Algarve Active Ageing - Cardiac and Osteoarthritis Rehabilitation (A3-COR) N/A
Completed NCT04167904 - Biomarkers in Patients Hospitalized With Suspected Acute Myocardial Infarction
Not yet recruiting NCT04989777 - IABP In AMI Patients With SCAI-B Study N/A
Recruiting NCT05043610 - MSCs for Prevention of MI-induced HF Phase 3